vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and QUINSTREET, INC (QNST). Click either name above to swap in a different company.
QUINSTREET, INC is the larger business by last-quarter revenue ($287.8M vs $168.4M, roughly 1.7× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 1.9%). Over the past eight quarters, QUINSTREET, INC's revenue compounded faster (53.2% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
QUINSTREET, INCQNSTEarnings & Financial Report
QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.
ESPR vs QNST — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $287.8M |
| Net Profit | — | $50.2M |
| Gross Margin | — | 9.6% |
| Operating Margin | 50.6% | 0.4% |
| Net Margin | — | 17.4% |
| Revenue YoY | 143.7% | 1.9% |
| Net Profit YoY | — | 3342.5% |
| EPS (diluted) | $0.32 | $0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $287.8M | ||
| Q3 25 | $87.3M | $285.9M | ||
| Q2 25 | $82.4M | — | ||
| Q1 25 | $65.0M | $269.8M | ||
| Q4 24 | $69.1M | $282.6M | ||
| Q3 24 | $51.6M | $279.2M | ||
| Q2 24 | $73.8M | $198.3M | ||
| Q1 24 | $137.7M | $168.6M |
| Q4 25 | — | $50.2M | ||
| Q3 25 | $-31.3M | $4.5M | ||
| Q2 25 | $-12.7M | — | ||
| Q1 25 | $-40.5M | $4.4M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-29.5M | $-1.4M | ||
| Q2 24 | $-61.9M | $-2.2M | ||
| Q1 24 | $61.0M | $-7.0M |
| Q4 25 | — | 9.6% | ||
| Q3 25 | — | 9.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 9.5% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | — | 8.5% |
| Q4 25 | 50.6% | 0.4% | ||
| Q3 25 | -11.4% | 1.7% | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | -34.0% | 1.8% | ||
| Q4 24 | -6.4% | -0.5% | ||
| Q3 24 | -31.0% | -0.4% | ||
| Q2 24 | 3.5% | -0.7% | ||
| Q1 24 | 52.5% | -3.2% |
| Q4 25 | — | 17.4% | ||
| Q3 25 | -35.9% | 1.6% | ||
| Q2 25 | -15.4% | — | ||
| Q1 25 | -62.2% | 1.6% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | -57.2% | -0.5% | ||
| Q2 24 | -83.9% | -1.1% | ||
| Q1 24 | 44.3% | -4.2% |
| Q4 25 | $0.32 | $0.87 | ||
| Q3 25 | $-0.16 | $0.08 | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.21 | $0.08 | ||
| Q4 24 | $-0.14 | $-0.03 | ||
| Q3 24 | $-0.15 | $-0.02 | ||
| Q2 24 | $-0.33 | $-0.04 | ||
| Q1 24 | $0.34 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $107.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $294.4M |
| Total Assets | $465.9M | $493.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $107.0M | ||
| Q3 25 | $92.4M | $101.3M | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | $81.8M | ||
| Q4 24 | $144.8M | $57.8M | ||
| Q3 24 | $144.7M | $25.0M | ||
| Q2 24 | $189.3M | $50.5M | ||
| Q1 24 | $226.6M | $39.6M |
| Q4 25 | $-302.0M | $294.4M | ||
| Q3 25 | $-451.4M | $246.7M | ||
| Q2 25 | $-433.5M | — | ||
| Q1 25 | $-426.2M | $235.5M | ||
| Q4 24 | $-388.7M | $224.3M | ||
| Q3 24 | $-370.2M | $219.8M | ||
| Q2 24 | $-344.2M | $216.8M | ||
| Q1 24 | $-294.3M | $215.0M |
| Q4 25 | $465.9M | $493.0M | ||
| Q3 25 | $364.0M | $442.6M | ||
| Q2 25 | $347.1M | — | ||
| Q1 25 | $324.0M | $417.2M | ||
| Q4 24 | $343.8M | $409.6M | ||
| Q3 24 | $314.1M | $401.2M | ||
| Q2 24 | $352.3M | $368.5M | ||
| Q1 24 | $373.1M | $349.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $21.6M |
| Free Cash FlowOCF − Capex | — | $20.7M |
| FCF MarginFCF / Revenue | — | 7.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 0.43× |
| TTM Free Cash FlowTrailing 4 quarters | — | $106.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $21.6M | ||
| Q3 25 | $-4.3M | $19.6M | ||
| Q2 25 | $-31.4M | — | ||
| Q1 25 | $-22.6M | $30.1M | ||
| Q4 24 | $-35.0M | $38.7M | ||
| Q3 24 | $-35.3M | $-13.7M | ||
| Q2 24 | $-7.2M | $16.6M | ||
| Q1 24 | $53.8M | $4.1M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | — | $18.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $29.5M | ||
| Q4 24 | — | $38.2M | ||
| Q3 24 | $-35.5M | $-14.1M | ||
| Q2 24 | $-7.3M | $15.4M | ||
| Q1 24 | $53.8M | $2.9M |
| Q4 25 | — | 7.2% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | -68.7% | -5.1% | ||
| Q2 24 | -9.9% | 7.8% | ||
| Q1 24 | 39.0% | 1.7% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | — | 0.43× | ||
| Q3 25 | — | 4.32× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 6.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
QNST
| Financial Service | $216.8M | 75% |
| Home Services And Other Revenue | $71.0M | 25% |
